/MSCL.V
MSCL.V Stock - Satellos Bioscience Inc.
Healthcare|BiotechnologyTSXV
$0.56+1.82%
+$0.01 (+1.82%) • Feb 14
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.93
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.72
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.62
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MSCL.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.55 – $0.57
TARGET (TP)$0.64
STOP LOSS$0.52
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.21
52W High$0.85
52W Low$0.29
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | $-336,948 | $-119,919 | $-48,161 | $-3,063 |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-8,406,661 | $-4,736,736 | $-1,545,248 | $-2,205,670 |
| Net Income | $-11,322,437 | $-15,505,652 | $-1,578,530 | $-1,938,235 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-0.32 | $-0.64 | $-0.05 | $-0.06 |
Company Overview
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MSCL.VBeat Rate
25%
Last 4 quarters
Avg Surprise
-0.9%
EPS vs Estimate
Beats / Misses
1/2
1 met exactly
Latest EPS
$-0.06
Q4 2023
EPS Surprise History
Q2 22
No data
Q3 22
No data
Q4 22
+28.6%
$-0.05vs$-0.07
Q4 22
No data
Q1 23
0.0%
$-0.05vs$-0.05
Q3 23
-22.6%
$-0.05vs$-0.04
Q4 23
-9.5%
$-0.03vs$-0.03
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Dec 31, 2023 | — | $-0.06 | — | — |
Q4 2023 | Nov 22, 2023 | $-0.03 | $-0.03 | -9.5% | ✗ MISS |
Q3 2023 | Aug 29, 2023 | $-0.04 | $-0.05 | -22.6% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.05 | $-0.05 | 0.0% | = MET |
Q4 2022 | Dec 31, 2022 | — | $-0.12 | — | — |
Q4 2022 | Nov 23, 2022 | $-0.07 | $-0.05 | +28.6% | ✓ BEAT |
Q3 2022 | Aug 29, 2022 | — | $-0.07 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.06 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.09 | — | — |
Q4 2021 | Nov 29, 2021 | — | $-0.43 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-0.03 | — | — |
Q4 2020 | Nov 24, 2020 | — | — | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | May 15, 2020 | — | — | — | — |
Q4 2019 | Nov 29, 2019 | — | — | — | — |
Q3 2019 | Aug 28, 2019 | — | — | — | — |
Q2 2019 | Apr 29, 2019 | — | — | — | — |
Q4 2018 | Nov 29, 2018 | — | — | — | — |
Q3 2018 | Aug 29, 2018 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about MSCL.V
What is MSCL.V's current stock price?
Satellos Bioscience Inc. (MSCL.V) is currently trading at $0.56 per share. The stock has moved +1.82% today.
What is the analyst price target for MSCL.V?
No analyst price targets are currently available for this stock.
What sector is Satellos Bioscience Inc. in?
Satellos Bioscience Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the TSXV exchange.
What is MSCL.V's market cap?
Satellos Bioscience Inc. has a market capitalization of $0.06 billion, making it a small-cap company.
Does MSCL.V pay dividends?
No, Satellos Bioscience Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACST.V
Acasti Pharma Inc.
$0.58
Mkt Cap: $0.0B
AEZS.TO
Aeterna Zentaris Inc.
$8.29
Mkt Cap: $0.0B
AIDR.CN
Rocket Doctor AI Inc.
$0.70
Mkt Cap: $0.1B
DRDR.TO
MCI Onehealth Technologies Inc.
$0.55
Mkt Cap: $0.0B
IGX.TO
IntelGenx Technologies Corp.
$0.24
Mkt Cap: $0.0B
MSET.CN
Mindset Pharma Inc.
$0.74
Mkt Cap: $0.1B
ONCO.CN
Onco-Innovations Ltd.
$1.47
Mkt Cap: $0.1B
PMN.TO
ProMIS Neurosciences, Inc.
$6.00
Mkt Cap: $0.1B
STEM.CN
Stem Holdings, Inc.
$0.31
Mkt Cap: $0.1B
TGOD.CN
The Green Organic Dutchman Holdings Ltd.
$0.38
Mkt Cap: $0.1B
Explore stocks similar to MSCL.V for comparison